35
GlaxoSmithKline Pharmaceuticals Limited
Statement of Profit and Loss for the year ended 31st December, 2012
Note
No.
Rupees
in lakhs
Previous year
Rupees
in lakhs
Sale of products ..
..
..
..
..
..
..
..
2669,97.28
2391,73.39
Excise duty
..
..
..
..
..
..
..
..
(70,04.18)
(53,69.99)
Sale of products (net)
..
..
..
..
..
..
..
2599,93.10
2338,03.40
Other operating revenue ..
..
..
..
..
..
..
30,37.21
37,84.70
Revenue from operations ..
..
..
..
..
..
..
29
2630,30.31
2375,88.10
Other Income
..
..
..
..
..
..
..
..
30
193,47.86
159,62.29
TOTAL REVENUE ..
2823,78.17
2535,50.39
Cost of materials consumed ..
..
..
..
..
..
..
31
437,80.90
431,23.54
Purchases of traded goods ..
..
..
..
..
..
..
32
607,45.49
533,36.71
Changes in inventories of finished goods, work-in-progress and traded goods ..
..
34
52,58.64
(56,09.05)
Employee benefits expense ..
..
..
..
..
..
..
35
295,51.55
278,36.31
Depreciation expense
..
..
..
..
..
..
..
11
17,83.93
20,40.78
Other expenses
..
..
..
..
..
..
..
36
417,80.01
406,62.32
TOTAL expenses ..
1829,00.52
1613,90.61
Profit before exceptional items and tax
..
..
..
..
..
994,77.65
921,59.78
Exceptional Items ..
..
..
..
..
..
..
..
41
(148,21.70)
(322,54.14)
Profit before Tax ..
..
..
..
..
..
..
..
846,55.95
599,05.64
Tax expense:
Current tax ..
..
..
..
..
..
..
..
294,37.55
180,67.74
Deferred tax ..
..
..
..
..
..
..
..
(25,07.49)
(5,07.07)
Fringe benefits tax – write back of provision for earlier years ..
..
..
(7,15.45)
Net Profit
..
..
..
..
..
..
..
..
577,25.89
430,60.42
Earnings per equity share (basic and diluted) (Rs.)
..
..
..
..
51
Face value Rs. 10 each ..
..
..
..
..
..
..
68.15
50.84
The accompanying notes are an integral part of these financial statements
This is the Statement of Profit and Loss referred to in our report of even date
For Price Waterhouse & Co., Bangalore
Firm Registration No. 007567S
Chartered Accountants
Asha Ramanathan
Partner
Membership No. 202660
For and on behalf of the Board
Vice-Chairman
V. Thyagarajan
Managing Director
Dr. H. B. Joshipura
Senior Executive Director
M. B. Kapadia
Company Secretary
A. A. Nadkarni
Mumbai, 19th February, 2013
Mumbai, 19th February, 2013
1...,29,30,31,32,33,34,35,36,37,38 40,41,42,43,44,45,46,47,48,49,...102